The findings revealed a remarkable cellular response wherein nutrient-starved cells reroute ER exit sites to lysosomes, organelles responsible for degrading and recycling cellular material.... Apr 16
Sanofi continues to give fresh impetus to its business in the Country with an accelerated growth plan - ‘India for India’, across its pharmaceuticals, specialty, consumer ... Mar 13
It is termed as a Beacon of Cybersecurity in Telangana. DGP Anjani Kumar, Principal Secretary Jayesh Ranjan unveiled amidst the presence of Commissioner of Cyberabad, ... Oct 23
This survey goes beyond identifying common illnesses; it also focuses on chronic health conditions and nutritional needs of pregnant women, new mothers, underweight individuals, and ... Sep 08
Celebrating World Rare Disease Day will create awareness and encourage patients to seek medical help on time to manage their condition.... Feb 28
Gene editing is a technique for making specific changes to a cell's or organism's DNA. It can be used to insert, remove, or ... Aug 30
Chronic disease management startup Phablecare has gained $25 million (Rs 187 crore) in its Series B funding round led by Kalaari Capital. ... Apr 12
India’s largest chronic disease management venture Phablecare has acquired a type 1 diabetes combating startup Fused Training.... Apr 02
Latest pharma news update... Nov 03
Latest pharma news update... Oct 04
Stay tuned and watch the entire episode of the lung cancer awareness series with Dr. Vikas knows the real cause of lung cancer which is ... Sep 01
Latest pharma news update... Aug 03
Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with ... Jun 18
Forge Biologics receives FDA fast track, orphan drug, and rare pediatric disease designations for FBX-101 gene therapy for patients with krabbe disease ... Feb 17
GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform... Dec 22
Polaryx Therapeutics, today announced that it has received from the U.S. Food and Drug Administration (FDA) both Rare Pediatric Disease and Orphan Drug Designations ... Dec 18
Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ... Dec 10
Polaryx Therapeutics has received from the US FDA both Rare Pediatric Disease and Orphan Drug designations for the treatment of GM2 gangliosidosis with PLX-300... Nov 25
The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa for long-term enzyme ... Nov 20
Common cold antibodies yield clues to COVID-19 behavior.... Nov 07
Public Citizen's Health Research Group said that the FDA should not approve aducanumab for treatment of Alzheimer's disease due to lack of evidence ... Nov 07
... Oct 30
... Oct 27
The acquisition of MyoKardia further strengthens Bristol Myers Squibb's portfolio, pipeline and scientific capabilities... Oct 12
Avalglucosidase alfa is an investigational enzyme replacement therapy, which, if approved, would offer a potential new standard of care for patients with Pompe disease... Oct 02
-Advertisements-
Friday, April 26, 2024
.jpg)
.jpg)
